996 related articles for article (PubMed ID: 32365221)
41. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
[TBL] [Abstract][Full Text] [Related]
42. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
[TBL] [Abstract][Full Text] [Related]
43. COVID-19 pneumonia: CD8
Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
[TBL] [Abstract][Full Text] [Related]
44. Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.
Peng Y; Meng K; He M; Zhu R; Guan H; Ke Z; Leng L; Wang X; Liu B; Hu C; Ji Q; Keerman M; Cheng L; Wu T; Huang K; Zeng Q
J Am Heart Assoc; 2020 Oct; 9(19):e016796. PubMed ID: 32794415
[TBL] [Abstract][Full Text] [Related]
45. Clinical and immunological features of severe and moderate coronavirus disease 2019.
Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
[TBL] [Abstract][Full Text] [Related]
46. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
47. Immune characteristics of severe and critical COVID-19 patients.
Yang L; Gou J; Gao J; Huang L; Zhu Z; Ji S; Liu H; Xing L; Yao M; Zhang Y
Signal Transduct Target Ther; 2020 Aug; 5(1):179. PubMed ID: 32868756
[No Abstract] [Full Text] [Related]
48. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
[TBL] [Abstract][Full Text] [Related]
49. Expressions of SAA, CRP, and FERR in different severities of COVID-19.
Liu SL; Wang SY; Sun YF; Jia QY; Yang CL; Cai PJ; Li JY; Wang L; Chen Y
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11386-11394. PubMed ID: 33215460
[TBL] [Abstract][Full Text] [Related]
50. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
[TBL] [Abstract][Full Text] [Related]
51. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
52. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.
Sun Y; Dong Y; Wang L; Xie H; Li B; Chang C; Wang FS
J Autoimmun; 2020 Aug; 112():102473. PubMed ID: 32439209
[TBL] [Abstract][Full Text] [Related]
53. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
[TBL] [Abstract][Full Text] [Related]
54. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.
Tan M; Liu Y; Zhou R; Deng X; Li F; Liang K; Shi Y
Immunology; 2020 Jul; 160(3):261-268. PubMed ID: 32460357
[TBL] [Abstract][Full Text] [Related]
55. Storm of soluble immune checkpoints associated with disease severity of COVID-19.
Kong Y; Wang Y; Wu X; Han J; Li G; Hua M; Han K; Zhang H; Li A; Zeng H
Signal Transduct Target Ther; 2020 Sep; 5(1):192. PubMed ID: 32895366
[No Abstract] [Full Text] [Related]
56. Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19.
Xu H; Hou K; Xu R; Li Z; Fu H; Wen L; Xie L; Liu H; Selvanayagam JB; Zhang N; Yang Z; Yang M; Guo Y
J Am Heart Assoc; 2020 Sep; 9(18):e016807. PubMed ID: 32806998
[TBL] [Abstract][Full Text] [Related]
57. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
58. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
[TBL] [Abstract][Full Text] [Related]
59. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study.
Liu QQ; Cheng A; Wang Y; Li H; Hu L; Zhao X; Wang T; He F
BMJ Open; 2020 Nov; 10(11):e041471. PubMed ID: 33257492
[TBL] [Abstract][Full Text] [Related]
60. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
